{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,3,1]],"date-time":"2026-03-01T09:12:57Z","timestamp":1772356377921,"version":"3.50.1"},"reference-count":29,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2022,9,1]],"date-time":"2022-09-01T00:00:00Z","timestamp":1661990400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2022,9,1]],"date-time":"2022-09-01T00:00:00Z","timestamp":1661990400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2022,9,1]],"date-time":"2022-09-01T00:00:00Z","timestamp":1661990400000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-017"},{"start":{"date-parts":[[2022,9,1]],"date-time":"2022-09-01T00:00:00Z","timestamp":1661990400000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-037"},{"start":{"date-parts":[[2022,9,1]],"date-time":"2022-09-01T00:00:00Z","timestamp":1661990400000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-012"},{"start":{"date-parts":[[2022,9,1]],"date-time":"2022-09-01T00:00:00Z","timestamp":1661990400000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-029"},{"start":{"date-parts":[[2022,9,1]],"date-time":"2022-09-01T00:00:00Z","timestamp":1661990400000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-004"}],"funder":[{"DOI":"10.13039\/100005564","name":"Gilead Sciences","doi-asserted-by":"publisher","award":["CO US 337 2031"],"award-info":[{"award-number":["CO US 337 2031"]}],"id":[{"id":"10.13039\/100005564","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100006093","name":"PCORI","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100006093","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","journalofsubstanceabusetreatment.com","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Journal of Substance Abuse Treatment"],"published-print":{"date-parts":[[2022,9]]},"DOI":"10.1016\/j.jsat.2022.108768","type":"journal-article","created":{"date-parts":[[2022,3,17]],"date-time":"2022-03-17T21:50:08Z","timestamp":1647553808000},"page":"108768","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":4,"special_numbering":"C","title":["Treatment for hepatitis C virus with direct acting antiviral agents: Perspectives and treatment experiences of people who inject drugs"],"prefix":"10.1016","volume":"140","author":[{"given":"Alison","family":"Karasz","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Reena","family":"Singh","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"M. Diane","family":"McKee","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Krupa","family":"Merchant","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Arthur Y.","family":"Kim","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Kimberly","family":"Page","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Irene","family":"Pericot-Valverde","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Ellen S.","family":"Stein","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Lynn E.","family":"Taylor","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Katherine","family":"Wagner","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Alain H.","family":"Litwin","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"key":"10.1016\/j.jsat.2022.108768_bb0005","series-title":"Recommendations for testing, managing, and treating hepatitis C","author":"AASLD-IDSA","year":"2019"},{"key":"10.1016\/j.jsat.2022.108768_bb0010","doi-asserted-by":"crossref","first-page":"66","DOI":"10.1016\/j.drugalcdep.2015.06.007","article-title":"\"Hepatitis C treatment turned me around\": Psychological and behavioral transformation related to hepatitis C treatment","volume":"153","author":"Batchelder","year":"2015","journal-title":"Drug and Alcohol Dependence"},{"issue":"11","key":"10.1016\/j.jsat.2022.108768_bb0015","doi-asserted-by":"crossref","first-page":"1593","DOI":"10.1007\/s00787-020-01503-w","article-title":"A dual perspective on first-session therapeutic alliance: Strong predictor of youth mental health and addiction treatment outcome","volume":"29","author":"van Benthem","year":"2020","journal-title":"European Child & Adolescent Psychiatry"},{"issue":"7","key":"10.1016\/j.jsat.2022.108768_bb0020","first-page":"535","article-title":"The therapeutic alliance as predictor in the treatment of young people","volume":"63","author":"van Benthem","year":"2021"},{"issue":"13\u201314","key":"10.1016\/j.jsat.2022.108768_bb0025","doi-asserted-by":"crossref","first-page":"641","DOI":"10.1007\/s00508-021-01868-1","article-title":"Challenges in hepatitis C elimination despite highly effective antiviral agents in patients with and without intravenous drug use","volume":"133","author":"Bota","year":"2021","journal-title":"Wiener Klinische Wochenschrift"},{"issue":"6","key":"10.1016\/j.jsat.2022.108768_bb0030","doi-asserted-by":"crossref","first-page":"755","DOI":"10.1016\/j.ijantimicag.2018.12.010","article-title":"Hepatitis C virus therapy: No one will be left behind","volume":"53","author":"Bourliere","year":"2019","journal-title":"International Journal of Antimicrobial Agents"},{"key":"10.1016\/j.jsat.2022.108768_bb0035","series-title":"Eliminating the public health problem of hepatitis B and C in the United States: Phase two report","author":"<collab>National Academies of Sciences","year":"2017"},{"issue":"5","key":"10.1016\/j.jsat.2022.108768_bb0040","doi-asserted-by":"crossref","first-page":"293","DOI":"10.7326\/M13-1133","article-title":"Chronic hepatitis C virus infection in the United States, national health and nutrition examination survey 2003 to 2010","volume":"160","author":"Denniston","year":"2014","journal-title":"Annals of Internal Medicine"},{"issue":"1","key":"10.1016\/j.jsat.2022.108768_bb0045","doi-asserted-by":"crossref","first-page":"69","DOI":"10.1186\/s12954-021-00519-y","article-title":"Therapy of chronic hepatitis C in people who inject drugs: Focus on adherence","volume":"18","author":"Frankova","year":"2021","journal-title":"Harm Reduction Journal"},{"issue":"5","key":"10.1016\/j.jsat.2022.108768_bb0050","doi-asserted-by":"crossref","first-page":"352","DOI":"10.1111\/j.1365-2893.2009.01080.x","article-title":"Low uptake of treatment for hepatitis C virus infection in a large community-based study of inner city residents","volume":"16","author":"Grebely","year":"2009","journal-title":"Journal of Viral Hepatitis"},{"issue":"11","key":"10.1016\/j.jsat.2022.108768_bb0055","doi-asserted-by":"crossref","first-page":"641","DOI":"10.1038\/nrgastro.2017.106","article-title":"Direct-acting antiviral agents for HCV infection affecting people who inject drugs","volume":"14","author":"Grebely","year":"2017","journal-title":"Nature Reviews. Gastroenterology & Hepatology"},{"issue":"11","key":"10.1016\/j.jsat.2022.108768_bb0060","doi-asserted-by":"crossref","first-page":"754","DOI":"10.1016\/S2468-1253(18)30304-2","article-title":"Direct-acting antiviral treatment for hepatitis C among people who use or inject drugs: A systematic review and meta-analysis","volume":"3","author":"Hajarizadeh","year":"2018","journal-title":"The Lancet Gastroenterology & Hepatology"},{"issue":"6","key":"10.1016\/j.jsat.2022.108768_bb0065","doi-asserted-by":"crossref","first-page":"742","DOI":"10.1080\/13548506.2013.774429","article-title":"Perspectives of a self-selected sample of former patients on the long-term health outcomes of interferon-based hepatitis C treatments: An exploratory study","volume":"18","author":"Hopwood","year":"2013","journal-title":"Psychology, Health & Medicine"},{"issue":"1","key":"10.1016\/j.jsat.2022.108768_bb0070","doi-asserted-by":"crossref","first-page":"33","DOI":"10.1016\/j.jhep.2018.09.030","article-title":"Association between rapid utilisation of direct hepatitis C antivirals and decline in the prevalence of viremia among people who inject drugs in Australia","volume":"70","author":"Iversen","year":"2019","journal-title":"Journal of Hepatology"},{"issue":"6","key":"10.1016\/j.jsat.2022.108768_bb0075","doi-asserted-by":"crossref","first-page":"494","DOI":"10.1176\/appi.psy.49.6.494","article-title":"Psychosocial issues in hepatitis C: A qualitative analysis","volume":"49","author":"Janke","year":"2008","journal-title":"Psychosomatics"},{"key":"10.1016\/j.jsat.2022.108768_bb0080","first-page":"105859","article-title":"Rationale and design of a randomized pragmatic trial of patient-centered models of hepatitis C treatment for people who inject drugs: The HERO study","volume":"87","author":"Litwin","year":"2019"},{"key":"10.1016\/j.jsat.2022.108768_bb0085","article-title":"HIV and HCV adherence and treatment outcomes among people who inject drugs receiving opioid agonist therapy","volume":"1\u20135","author":"Minhas","year":"2021","journal-title":"AIDS Care"},{"issue":"1","key":"10.1016\/j.jsat.2022.108768_bb0090","doi-asserted-by":"crossref","first-page":"44","DOI":"10.1186\/s12954-019-0314-6","article-title":"HCV treatment access among latinxs who inject drugs: Qualitative findings from Boston, Massachusetts, 2016","volume":"16","author":"Mittal","year":"2019","journal-title":"Harm Reduction Journal"},{"key":"10.1016\/j.jsat.2022.108768_bb0095","doi-asserted-by":"crossref","first-page":"196","DOI":"10.1016\/j.drugpo.2017.07.021","article-title":"High HCV cure rates for people who use drugs treated with direct acting antiviral therapy at an urban primary care clinic","volume":"47","author":"Norton","year":"2017","journal-title":"The International Journal on Drug Policy"},{"issue":"10","key":"10.1016\/j.jsat.2022.108768_bb0100","article-title":"Low adherence achieves high HCV cure rates among people who inject drugs treated with direct-acting antiviral agents","volume":"7","author":"Norton","year":"2020"},{"issue":"1","key":"10.1016\/j.jsat.2022.108768_bb0105","doi-asserted-by":"crossref","first-page":"13","DOI":"10.1016\/S0277-9536(02)00304-0","article-title":"HIV and AIDS-related stigma and discrimination: A conceptual framework and implications for action","volume":"57","author":"Parker","year":"2003","journal-title":"Soc Sci Med"},{"key":"10.1016\/j.jsat.2022.108768_bb0110","doi-asserted-by":"crossref","first-page":"994","DOI":"10.1186\/s12889-016-3671-z","article-title":"Facilitators of HCV treatment adherence among people who inject drugs: A systematic qualitative review and implications for scale up of direct acting antivirals","volume":"16","author":"Rich","year":"2016","journal-title":"BMC Public Health"},{"issue":"16","key":"10.1016\/j.jsat.2022.108768_bb0115","doi-asserted-by":"crossref","first-page":"2282","DOI":"10.1111\/j.1365-2702.2009.02806.x","article-title":"Living with hepatitis C and treatment: The personal experiences of patients","volume":"18","author":"Sgorbini","year":"2009","journal-title":"Journal of Clinical Nursing"},{"key":"10.1016\/j.jsat.2022.108768_bb0120","doi-asserted-by":"crossref","first-page":"246","DOI":"10.1016\/j.drugalcdep.2018.06.013","article-title":"'Hep C's like the common cold': Understanding barriers along the HCV care continuum among young people who inject drugs","volume":"190","author":"Skeer","year":"2018","journal-title":"Drug and Alcohol Dependence"},{"key":"10.1016\/j.jsat.2022.108768_bb0125","series-title":"Basics of qualitative research: Techniques and procedures for developing grounded theory","author":"Strauss","year":"1998"},{"issue":"10","key":"10.1016\/j.jsat.2022.108768_bb0130","doi-asserted-by":"crossref","first-page":"1411","DOI":"10.1093\/cid\/ciu643","article-title":"Emerging epidemic of hepatitis C virus infections among young nonurban persons who inject drugs in the United States, 2006\u20132012","volume":"59","author":"Suryaprasad","year":"2014","journal-title":"Clinical Infectious Diseases"},{"key":"10.1016\/j.jsat.2022.108768_bb0135","article-title":"Patient assessments of the factors facilitating and impeding user involvement during the first phase of substance abuse treatment","volume":"15","author":"Wenaas","year":"2021","journal-title":"Subst Abuse"},{"issue":"5","key":"10.1016\/j.jsat.2022.108768_bb0140","doi-asserted-by":"crossref","first-page":"531","DOI":"10.1097\/PSY.0b013e31817749dc","article-title":"Trauma, mental health, distrust, and stigma among HIV-positive persons: Implications for effective care","volume":"70","author":"Whetten","year":"2008","journal-title":"Psychosomatic Medicine"},{"issue":"2","key":"10.1016\/j.jsat.2022.108768_bb0145","doi-asserted-by":"crossref","first-page":"175","DOI":"10.2105\/AJPH.2017.304132","article-title":"Increases in acute hepatitis C virus infection related to a growing opioid epidemic and associated injection drug use, United States, 2004 to 2014","volume":"108","author":"Zibbell","year":"2018","journal-title":"American Journal of Public Health"}],"container-title":["Journal of Substance Abuse Treatment"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0740547222000502?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0740547222000502?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,10,9]],"date-time":"2025-10-09T19:57:00Z","timestamp":1760039820000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0740547222000502"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2022,9]]},"references-count":29,"alternative-id":["S0740547222000502"],"URL":"https:\/\/doi.org\/10.1016\/j.jsat.2022.108768","relation":{},"ISSN":["0740-5472"],"issn-type":[{"value":"0740-5472","type":"print"}],"subject":[],"published":{"date-parts":[[2022,9]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Treatment for hepatitis C virus with direct acting antiviral agents: Perspectives and treatment experiences of people who inject drugs","name":"articletitle","label":"Article Title"},{"value":"Journal of Substance Abuse Treatment","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.jsat.2022.108768","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2022 Elsevier Inc. All rights reserved.","name":"copyright","label":"Copyright"}],"article-number":"108768"}}